These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6105681)

  • 1. New findings on the neuropharmacological control of food intake.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Pharmacol Res Commun; 1980 Jun; 12(6):599-603. PubMed ID: 6105681
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
    Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
    Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite regulation by drugs and endogenous substances.
    Sullivan AC; Triscari J; Cheng L
    Curr Concepts Nutr; 1983; 12():139-67. PubMed ID: 6303697
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
    Carruba MO; Ricciardi S; Mantegazza P
    Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
    [No Abstract]   [Full Text] [Related]  

  • 6. Anorectic effect of SK & F 38393, a new dopamine agonist in rats.
    Girdhar A; Sharma DC; Sachdev KS
    Indian J Physiol Pharmacol; 1982; 26(4):317-20. PubMed ID: 6984016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Insight: appetite suppressants.
    Bray GA
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):89-95. PubMed ID: 16265126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of adreno- and dopamine-reactive systems in the central action of caffeine].
    Kurbat NM; Korablev MV
    Farmakol Toksikol; 1981; 44(5):559-61. PubMed ID: 7198054
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 11. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Golozoubova V; Strauss F; Malmlöf K
    Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The central nervous system and appetite: possible sites of activity for food intake therapy].
    Lombardi C; Govoni S; Trabucchi M
    Minerva Med; 1984 Jul; 75(30-31):1781-90. PubMed ID: 6090990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors.
    Ebenezer IS; Arkle MJ; Tite RM
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):269-72. PubMed ID: 17609739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-induced stereotypy: reply to Rebec and Bashore.
    Kokkinidis L; Anisman H
    Psychol Bull; 1983 Mar; 93(2):368-72. PubMed ID: 6682558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of memantine on central neurotransmitter systems. Review of the results].
    Maj J
    Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
    Verty AN; McGregor IS; Mallet PE
    Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorectic activity of 2H-4,6-dimethyl-2-[(4-phenylpiperazin-1- yl)methyl]-3-oxo-2,3-dihydroisothiazolo[5,4-b]pyridine.
    Rutkowska M
    Acta Pol Pharm; 1999; 56(1):91-2. PubMed ID: 10635354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anorectic effect of the selective dopamine D1-receptor agonist A-77636 determined by meal pattern analysis in free-feeding rats.
    Cooper SJ; Al-Naser HA; Clifton PG
    Eur J Pharmacol; 2006 Feb; 532(3):253-7. PubMed ID: 16478622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.